Detalhe da pesquisa
1.
An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE).
Am J Respir Crit Care Med
; 207(2): 138-149, 2023 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35972987
2.
Specific in situ immuno-imaging of pulmonary-resident memory lymphocytes in human lungs.
Front Immunol
; 14: 1100161, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36845117
3.
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics.
EBioMedicine
; 76: 103856, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35152152